Consensus Medical Properties Trust, Inc.

Equities

MPW

US58463J3041

Market Closed - Nyse Other stock markets 04:00:01 2024-04-26 pm EDT			5-day change	1st Jan Change
4.51 ^USD	-1.10%		+2.04%	-8.15%

Apr. 17	Deutsche Bank Upgrades Medical Properties Trust to Hold From Sell, Adjusts PT to $5 From $2	MT
Apr. 15	Sector Update: Financial Stocks Sliding Late Afternoon	MT

Evolution of the average Target Price on Medical Properties Trust, Inc.

Price target over the last 5 years

History of analyst recommendation changes

7b7a465.xgK9mIbn1d8zl0RjAu2w8BdfK0TsFK__Zxcbqh3CPLI.9FXkwMC2s6dyyC0bVNXEiE8TewqEJZyGMTp99XeWe_mQVunQt6-cnXGvFQ~69942aaa7eb4707e4488f4d43e40995a

Analyst Recommendations on Medical Properties Trust, Inc.

Deutsche Bank Upgrades Medical Properties Trust to Hold From Sell, Adjusts PT to $5 From $2	Apr. 17	MT
Truist Securities Raises Price Target on Medical Properties Trust to $4.50 From $4, Maintains Hold Rating	Apr. 08	MT
BNP Paribas Exane Upgrades Medical Properties Trust to Outperform From Neutral, Price Target is $6	Mar. 01	MT
RBC Cuts Price Target on Medical Properties Trust to $5 From $8 on Steward-Related Rent Disruption, Keeps Outperform, Speculative Risk	Feb. 20	MT
KeyBanc Downgrades Medical Properties Trust to Sector Weight From Overweight, Removes $15 Price Target Amid Uncertainty, Risks to Tenant Health	Jan. 05	MT
Mizuho Securities Adjusts Medical Properties Trust's Price Target to $7 From $9, Keeps Neutral Rating	Jan. 03	MT
RBC Cuts Price Target on Medical Properties Trust to $8 From $10, Keeps Outperform Rating	Nov. 28	MT
Stifel Downgrades Medical Properties Trust to Hold From Buy, Adjusts Price Target to $4.50 From $12	Nov. 10	MT
Wells Fargo Downgrades Medical Properties Trust to Underweight From Equalweight, Cuts Price Target to $4 From $7	23-10-16	MT
Mizuho Downgrades Medical Properties Trust to Neutral From Buy, Adjusts Price Target to $9 From $18	23-08-31	MT
Barclays Adjusts Price Target on Medical Properties Trust to $10 From $12, Maintains Overweight Rating	23-08-22	MT
JPMorgan Downgrades Medical Properties Trust to Underweight From Neutral, Adjusts Price Target to $7 From $9	23-08-21	MT
ANALYST RECOMMENDATIONS : Alphabet, AstraZeneca, FMC Corp, Target, Wise...	23-08-21
RBC Adds Speculative Risk Qualifier to Outperform Rating on Medical Properties Trust, Cuts PT to $10 From $12 After 'Disappointing' Q2 Results	23-08-14	MT
BofA Securities Downgrades Medical Properties Trust to Underperform From Neutral, Adjusts Price Target to $8 From $9	23-08-11	MT
Raymond James Downgrades Medical Properties Trust to Underperform From Strong Buy	23-08-11	MT
Truist Securities Adjusts Medical Properties Trust Price Target to $10 From $9, Maintains Hold Rating	23-06-23	MT
Wells Fargo Starts Medical Properties Trust at Equalweight With $9 Price Target	23-04-20	MT
Barclays Adjusts Price Target on Medical Properties Trust to $12 From $14, Keeps Overweight Rating	23-04-05	MT
Keybanc Trims Price Target on Medical Properties Trust to $15 From $16, Keeps Overweight Rating	23-04-04	MT
Truist Securities Adjusts Price Target on Medical Properties Trust to $9 From $8, Maintains Hold Rating	23-03-31	MT
Truist Securities Adjusts Medical Properties Trust's Price Target to $8 From $14, Keeps Hold Rating	23-03-29	MT
BofA Securities Downgrades Medical Properties Trust to Neutral From Buy, Adjusts Price Target to $10 From $13	23-03-16	MT
JPMorgan Adjusts Medical Properties Trust's Price Target to $12 From $14, Keeps Neutral Rating	23-03-03	MT
Raymond James Adjusts Price Target on Medical Properties Trust to $16 From $18, Maintains Strong Buy Rating	23-03-02	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

4.51 USD

Average target price

4.955 USD

Spread / Average Target

+9.87%

High Price Target

7 USD

Spread / Highest target

+55.21%

Low Price Target

4 USD

Spread / Lowest Target

-11.31%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Medical Properties Trust, Inc.

Deutsche Bank Securities
Truist Securities
BNP Paribas Exane
RBC Capital Markets
KeyBanc Capital Markets
Mizuho Securities
Stifel Nicolaus
Wells Fargo Securities
Barclays
JPMorgan Chase
BofA Securities
Raymond James
Credit Suisse
Berenberg Bank
Jefferies & Co.
Wolfe Research

Ratings for Medical Properties Trust, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar